---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004253"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:21:59.086051+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals prices $1.37M registered direct offering and private placement

## Summary
- Offering of 366,000 shares (or pre-funded warrants) at $3.75/share, with common warrants exercisable at $3.62.
- Gross proceeds expected $1.37M; net proceeds for working capital and general corporate purposes.
- Closing expected on or about June 17, 2024, subject to customary closing conditions.
- Warrants expire 5 years from issuance; cashless exercise if no effective registration statement.

## SEC filing metadata
- accession: 0001683168-24-004253
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004253/0001683168-24-004253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004253/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004253
- JSON: https://secwatch.observer/filing/0001683168-24-004253.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.